Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.

<h4>Background</h4>Agitation in Alzheimer's disease (AD) is common and associated with poor patient life-quality and carer distress. The best evidence-based pharmacological treatments are antipsychotics which have limited benefits with increased morbidity and mortality. There are no...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Chris Fox, Monica Crugel, Ian Maidment, Bjorn Henrik Auestad, Simon Coulton, Adrian Treloar, Clive Ballard, Malaz Boustani, Cornelius Katona, Gill Livingston
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2012
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/a3d8c3e29aee45faa42cf52f69ff9836
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!